Related Experiment Video
Updated: Apr 25, 2026
Mouse Heterotopic Cervical Cardiac Transplantation Utilizing Vascular Cuffs
Published on: June 23, 2022
[Cardiac graft allocation]
Insights
French cardiac graft allocation prioritizes local teams and national lists for critical patients. While HE1 patients show poorer survival, their transplantation offers greater survival benefits, necessitating careful graft acceptance and multidisciplinary decisions for fairness.
Area of Science:
- Cardiology
- Transplantation Medicine
- Public Health Policy
Context:
- French cardiac graft allocation evolved from center-based to include national priority lists (HE1 and HE2) in 2004.
- HE1 designates patients with unstable hemodynamics (inotropes, ECMO), while HE2 is for those with complications during long-term circulatory support.
- Initial data suggest poorer survival for HE1 patients compared to HE2 patients.
Purpose:
- To analyze the French cardiac graft allocation system, evaluating the impact of national priority lists (HE1, HE2) on patient survival.
- To examine the complexities beyond allocation rules, including graft quality assessment and patient risk stratification for waiting list inclusion.
- To underscore the need for a multidisciplinary approach in cardiac transplantation decision-making.
Summary:
- While HE1 patients exhibit lower survival rates, their potential survival benefit post-transplantation is significantly higher than HE2 patients.
- Mortality during long-term circulatory support is a critical factor not fully captured in HE2 survival data.
- Graft quality and individual patient risk assessment introduce heterogeneity, impacting waiting times and transplant outcomes.
- The study highlights that medical decisions, independent of allocation rules, significantly influence transplant success and fairness.
Impact:
- The findings emphasize that current allocation rules do not fully account for the nuances of patient acuity and graft quality.
- A multidisciplinary decision-making process is crucial for ensuring equitable and effective cardiac graft allocation.
- This research informs policy and clinical practice to optimize cardiac transplantation outcomes and fairness across the national waiting list.
Abstract:
Until 2004, French rules for cardiac graft allocation were aimed at ensuring uniform organ distribution on the national scale, while logically giving priority to local teams. The allocation was center-based, with transplant MDs choosing the most suitable recipient from the local waiting list. In 2004, two national priority lists were added to the French cardiac graft allocation system. High Emergency 1 (HE1) is for patients with unstable hemodynamic status (on inotropes or ECMO), while High Emergency 2 (HE2) is for patients who develop complications during long-term circulatory support. Data from the French Biomedicines Agency show significantly poorer survival for HE1 patients than for HE2 patients. However, this should not lead to the conclusion that HE2 is a better strategy, as mortality during long-term circulatory support is not taken into account, and it is well known that the survival benefit of transplantation is significantly better in HE1 patients. Furthermore, the risk related to the quality of the cardiac graft must be taken into account. Indeed, the decision to transplant or not to transplant an HE1 patient with a given graft will impact not only the survival of the patient concerned, but also the waiting time of the other patients on the list, independently of allocation rules. This is also true for the criteria used to place a patient on the waiting list. Each cardiac transplantation team considers the level of risk before adding a patient to the waiting list, and this will impact not only the individual candidate but also the entire waiting list. Thus, even if allocation rules aim to provide all patients with the same chance of being transplanted across the entire country, the medical decision to accept a cardiac graft and to register a patient on the waiting list will make this process somewhat heterogeneous. This allows cardiac transplantation to be adapted to each individual case, independently of the rules. However, a multidisciplinary decision process is necessary to ensure fairness.
